506 related articles for article (PubMed ID: 19054418)
1. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.
Fattouch J; Di Bonaventura C; Casciato S; Bonini F; Petrucci S; Lapenta L; Manfredi M; Prencipe M; Giallonardo AT
Acta Neurol Scand; 2010 Jun; 121(6):418-21. PubMed ID: 20578996
[TBL] [Abstract][Full Text] [Related]
3. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
Eue S; Grumbt M; Müller M; Schulze A
Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study.
Aiguabella M; Falip M; Villanueva V; de la Peña P; Molins A; Garcia-Morales I; Saiz RA; Pardo J; Tortosa D; Sansa G; Miró J
Seizure; 2011 Jan; 20(1):60-4. PubMed ID: 21145758
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
7. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
Snoeck E; Jacqmin P; Sargentini-Maier ML; Stockis A
Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
[TBL] [Abstract][Full Text] [Related]
8. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
Atmaca MM; Orhan EK; Bebek N; Gurses C
Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
[TBL] [Abstract][Full Text] [Related]
9. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
McTague A; Kneen R; Kumar R; Spinty S; Appleton R
Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
[TBL] [Abstract][Full Text] [Related]
10. Use of levetiracetam in hospitalized patients.
Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
Patterson EE; Goel V; Cloyd JC; O'Brien TD; Fisher JE; Dunn AW; Leppik IE
J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147
[TBL] [Abstract][Full Text] [Related]
12. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
13. Intravenous levetiracetam for epileptic seizure emergencies in older people.
Beyenburg S; Reuber M; Maraite N
Gerontology; 2009; 55(1):27-31. PubMed ID: 18953167
[TBL] [Abstract][Full Text] [Related]
14. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.
Knake S; Gruener J; Hattemer K; Klein KM; Bauer S; Oertel WH; Hamer HM; Rosenow F
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):588-9. PubMed ID: 17898030
[TBL] [Abstract][Full Text] [Related]
15. Determinants of success in the use of oral levetiracetam in status epilepticus.
Rossetti AO; Bromfield EB
Epilepsy Behav; 2006 May; 8(3):651-4. PubMed ID: 16495155
[TBL] [Abstract][Full Text] [Related]
16. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
[TBL] [Abstract][Full Text] [Related]
17. Role of intravenous levetiracetam in acute seizure management of children.
Kirmani BF; Crisp ED; Kayani S; Rajab H
Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
[TBL] [Abstract][Full Text] [Related]
18. Intravenous levetiracetam in clinical practice--Results from an independent registry.
Lang N; Esser W; Evers S; Kellinghaus C; Nguento A; Schlegel U; Gaida B; Gburek-Augustat J; Altenmüller DM; Burghaus L; Hoffmann F; Fiedler B; Bast T; Rehfeld T; Happe S; Seitz RJ; Boor R; Stephani U
Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
[TBL] [Abstract][Full Text] [Related]
19. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
Cilio MR; Bianchi R; Balestri M; Onofri A; Giovannini S; Di Capua M; Vigevano F
Epilepsy Res; 2009 Sep; 86(1):66-71. PubMed ID: 19520548
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus.
Ulvi H; Yoldas T; Müngen B; Yigiter R
Neurol Sci; 2002 Oct; 23(4):177-82. PubMed ID: 12536286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
